FDA Approves Erelzi (etanercept-szzs), a Biosimilar to Enbrel

August 30, 2016 -- The U.S. Food and Drug Administration today approved Erelzi, (etanercept-szzs) for multiple inflammatory diseases. Erelzi is a biosimilar to Enbrel (etanercept), which was originally licensed in 1998. Erelzi is administered by...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news